SVP F&A, CFO, Treas & Asst Sec of Regeneron Pharmaceuticals Inc. (REGN) Murray A Goldberg sells 4,569 shares of REGN on 02/18/2011 at an average price of $37.18 a share.

Regeneron Pharmaceuticals Inc. has a market cap of $3.1 billion; its shares were traded at around $37.67 with and P/S ratio of 8.2.

Hedge Fund Gurus that owns REGN: Seth Klarman of The Baupost Group, Carl Icahn of Icahn Capital Management LP, Bruce Kovner of Caxton Associates, Jim Simons of Renaissance Technologies LLC, Steven Cohen of SAC Capital Advisors. Mutual Fund and Other Gurus that owns REGN: Edward Owens of Vanguard Health Care Fund, Chuck Royce of Royce& Associates.

CFO Recent Trades:

• Sell: SVP F&A, CFO, Treas & Asst Sec Murray A Goldberg sold 5,885 shares of REGN stock on 02/14/2011 at the average price of 37.32. Murray A Goldberg owns at least 82,870 shares after this. The price of the stock has increased by 0.94% since.


• Sell: SVP F&A, CFO, Treas & Asst Sec Murray A Goldberg sold 7,373 shares of REGN stock on 01/07/2011 at the average price of 34.09. Murray A Goldberg owns at least 82,870 shares after this. The price of the stock has increased by 10.5% since.


• Sell: SVP F&A, CFO, Treas & Asst Sec Murray A Goldberg sold 5,168 shares of REGN stock on 12/17/2010 at the average price of 32.15. Murray A Goldberg owns at least 48,870 shares after this. The price of the stock has increased by 17.17% since.


• Sell: SVP F&A, CFO, Treas & Asst Sec Murray A Goldberg sold 5,168 shares of REGN stock on 12/17/2010 at the average price of 32.15. Murray A Goldberg owns at least 48,870 shares after this. The price of the stock has increased by 17.17% since.

This is the insider trade history vs. stock price of REGN. For the complete insider trading history of REGN, click here.

Directors and Officers Recent Trades:

• Buy: 10% Owner Sanofi-aventis bought 1,017,401 shares of REGN stock on 10/13/2010 at the average price of 28. Sanofi-aventis owns at least 15,816,953 shares after this. The price of the stock has increased by 34.54% since.


• Sell: SVP Commercial Robert J Terifay sold 5,000 shares of REGN stock on 02/14/2011 at the average price of 37.02. Robert J Terifay owns at least 1,106 shares after this. The price of the stock has increased by 1.76% since.


• Sell: Director Joseph L Goldstein sold 2,761 shares of REGN stock on 02/11/2011 at the average price of 36.66. The price of the stock has increased by 2.76% since.


• Sell: Director Joseph L Goldstein sold 5,401 shares of REGN stock on 01/27/2011 at the average price of 34.67. The price of the stock has increased by 8.65% since.


• Sell: VP Regul Devel & Med Safety William Roberts sold 2,693 shares of REGN stock on 01/26/2011 at the average price of 34.49. William Roberts owns at least 88,209 shares after this. The price of the stock has increased by 9.22% since.

For the complete insider trading history of REGN, click here.

Why CEOs Are Buying Stocks Of Their Own Companies?

1. As legendary investor Peter Lynch said: "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise."
2. TOP EXECUTIVES like CEOs and CFOs are savvy buyers of their companies' shares. One long-term study showed that they beat the market on average by six percentage points a year.
3. Another study found that the aggregated activities of insiders can serve as a good indicator to locate market bottoms. Insiders as a whole are smart investors of their own companies.

Click it to Check Out What the CEO Are Trading

More Gurufocus Links

Latest Guru Picks	Value Strategies
Warren Buffett Portfolio	Ben Graham Net-Net
Real Time Picks	Buffett-Munger Screener
Aggregated Portfolio	Undervalued Predictable
ETFs, Options	Low P/S Companies
Insider Trends	10-Year Financials
52-Week Lows	Interactive Charts
Model Portfolios	DCF Calculator
RSS Feed	Monthly Newsletters
The All-In-One Screener	Portfolio Tracking Tool